Caden Capital Partners LP Buys 95,379 Shares of STERIS plc (NYSE:STE)

Caden Capital Partners LP raised its stake in shares of STERIS plc (NYSE:STE - Free Report) by 119.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 175,358 shares of the medical equipment provider's stock after buying an additional 95,379 shares during the period. STERIS comprises about 11.0% of Caden Capital Partners LP's portfolio, making the stock its 5th largest holding. Caden Capital Partners LP owned 0.18% of STERIS worth $36,047,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. Avalon Trust Co acquired a new stake in STERIS in the fourth quarter valued at approximately $30,000. Human Investing LLC acquired a new stake in shares of STERIS in the fourth quarter valued at about $31,000. Anfield Capital Management LLC increased its stake in shares of STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after purchasing an additional 91 shares in the last quarter. Central Pacific Bank Trust Division raised its position in shares of STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after purchasing an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC lifted its stake in STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after buying an additional 137 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.

Analyst Ratings Changes

Several research analysts recently commented on STE shares. JMP Securities reissued a "market outperform" rating and issued a $265.00 price objective on shares of STERIS in a research note on Thursday, April 10th. Needham & Company LLC restated a "hold" rating on shares of STERIS in a research report on Monday, April 7th. Piper Sandler increased their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Finally, Stephens restated an "overweight" rating and set a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $258.75.

STERIS Stock Performance

Shares of STE stock traded down $2.41 during mid-day trading on Thursday, hitting $222.33. 1,088,982 shares of the stock were exchanged, compared to its average volume of 536,853. STERIS plc has a 12-month low of $200.98 and a 12-month high of $248.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The stock has a market capitalization of $21.84 billion, a price-to-earnings ratio of 47.20 and a beta of 0.87. The stock's fifty day simple moving average is $223.12 and its two-hundred day simple moving average is $218.91.

STERIS (NYSE:STE - Get Free Report) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, analysts forecast that STERIS plc will post 9.08 EPS for the current year.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.